ASTRAZENECA COVID VACCINE GETS SUPPORT FROM NIH DIRECTOR

Highlights:

• The head of the National Institutes of Health, Francis Collins told to Congress that a pause of the phase three trial of the AstraZeneca's COVID-19 vaccine is not unprecedented and must be reassuring.
• AstraZeneca said on Tuesday that the late-stage vaccine trials were being  Click here to read more